nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—CYP1A1—chronic obstructive pulmonary disease	0.196	0.509	CbGaD
Quinidine—CYP1A2—chronic obstructive pulmonary disease	0.189	0.491	CbGaD
Quinidine—SLC22A4—Tiotropium—chronic obstructive pulmonary disease	0.0995	0.22	CbGbCtD
Quinidine—SLC22A5—Tiotropium—chronic obstructive pulmonary disease	0.0562	0.124	CbGbCtD
Quinidine—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.0369	0.0816	CbGbCtD
Quinidine—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0269	0.0595	CbGbCtD
Quinidine—SLCO1A2—Prednisolone—chronic obstructive pulmonary disease	0.0263	0.0583	CbGbCtD
Quinidine—SLCO1A2—Prednisone—chronic obstructive pulmonary disease	0.0249	0.055	CbGbCtD
Quinidine—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0179	0.0397	CbGbCtD
Quinidine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0165	0.0365	CbGbCtD
Quinidine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0165	0.0365	CbGbCtD
Quinidine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0156	0.0344	CbGbCtD
Quinidine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0151	0.0334	CbGbCtD
Quinidine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0151	0.0334	CbGbCtD
Quinidine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0134	0.0297	CbGbCtD
Quinidine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0127	0.028	CbGbCtD
Quinidine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0125	0.0277	CbGbCtD
Quinidine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00855	0.0189	CbGbCtD
Quinidine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00815	0.018	CbGbCtD
Quinidine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00727	0.0161	CbGbCtD
Quinidine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00712	0.0157	CbGbCtD
Quinidine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00672	0.0149	CbGbCtD
Quinidine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00426	0.00944	CbGbCtD
Quinidine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00403	0.00891	CbGbCtD
Quinidine—Quinine—CYP1A1—chronic obstructive pulmonary disease	0.00124	0.509	CrCbGaD
Quinidine—Quinine—CYP1A2—chronic obstructive pulmonary disease	0.0012	0.491	CrCbGaD
Quinidine—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000269	0.00241	CcSEcCtD
Quinidine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000269	0.00241	CcSEcCtD
Quinidine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000269	0.00241	CcSEcCtD
Quinidine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.0024	CcSEcCtD
Quinidine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000269	0.0024	CcSEcCtD
Quinidine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000268	0.00239	CcSEcCtD
Quinidine—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00239	CcSEcCtD
Quinidine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00239	CcSEcCtD
Quinidine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000267	0.00239	CcSEcCtD
Quinidine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000267	0.00239	CcSEcCtD
Quinidine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000266	0.00238	CcSEcCtD
Quinidine—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000266	0.00237	CcSEcCtD
Quinidine—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000266	0.00237	CcSEcCtD
Quinidine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000264	0.00236	CcSEcCtD
Quinidine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000263	0.00235	CcSEcCtD
Quinidine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000262	0.00234	CcSEcCtD
Quinidine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000262	0.00234	CcSEcCtD
Quinidine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000261	0.00233	CcSEcCtD
Quinidine—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00233	CcSEcCtD
Quinidine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00232	CcSEcCtD
Quinidine—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00231	CcSEcCtD
Quinidine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000254	0.00227	CcSEcCtD
Quinidine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.00226	CcSEcCtD
Quinidine—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000252	0.00225	CcSEcCtD
Quinidine—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000251	0.00224	CcSEcCtD
Quinidine—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.00025	0.00223	CcSEcCtD
Quinidine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000249	0.00222	CcSEcCtD
Quinidine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000249	0.00222	CcSEcCtD
Quinidine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000248	0.00221	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000245	0.00219	CcSEcCtD
Quinidine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000244	0.00218	CcSEcCtD
Quinidine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000244	0.00218	CcSEcCtD
Quinidine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000244	0.00218	CcSEcCtD
Quinidine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.00217	CcSEcCtD
Quinidine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000243	0.00217	CcSEcCtD
Quinidine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000239	0.00214	CcSEcCtD
Quinidine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000238	0.00213	CcSEcCtD
Quinidine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.0021	CcSEcCtD
Quinidine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000235	0.0021	CcSEcCtD
Quinidine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.0021	CcSEcCtD
Quinidine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000233	0.00208	CcSEcCtD
Quinidine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000232	0.00207	CcSEcCtD
Quinidine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.00206	CcSEcCtD
Quinidine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00023	0.00206	CcSEcCtD
Quinidine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.00205	CcSEcCtD
Quinidine—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000227	0.00203	CcSEcCtD
Quinidine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000226	0.00202	CcSEcCtD
Quinidine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00202	CcSEcCtD
Quinidine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00202	CcSEcCtD
Quinidine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00202	CcSEcCtD
Quinidine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00202	CcSEcCtD
Quinidine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000225	0.00202	CcSEcCtD
Quinidine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00201	CcSEcCtD
Quinidine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000225	0.00201	CcSEcCtD
Quinidine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000225	0.00201	CcSEcCtD
Quinidine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00201	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000225	0.00201	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000225	0.00201	CcSEcCtD
Quinidine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00198	CcSEcCtD
Quinidine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000222	0.00198	CcSEcCtD
Quinidine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.00197	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00022	0.00197	CcSEcCtD
Quinidine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00022	0.00196	CcSEcCtD
Quinidine—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000219	0.00195	CcSEcCtD
Quinidine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000217	0.00194	CcSEcCtD
Quinidine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.00194	CcSEcCtD
Quinidine—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000216	0.00193	CcSEcCtD
Quinidine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00191	CcSEcCtD
Quinidine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00191	CcSEcCtD
Quinidine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000213	0.00191	CcSEcCtD
Quinidine—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000213	0.0019	CcSEcCtD
Quinidine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000213	0.0019	CcSEcCtD
Quinidine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000213	0.0019	CcSEcCtD
Quinidine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000212	0.0019	CcSEcCtD
Quinidine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000212	0.0019	CcSEcCtD
Quinidine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.00189	CcSEcCtD
Quinidine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000212	0.00189	CcSEcCtD
Quinidine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000211	0.00188	CcSEcCtD
Quinidine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.00188	CcSEcCtD
Quinidine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000211	0.00188	CcSEcCtD
Quinidine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00021	0.00188	CcSEcCtD
Quinidine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000208	0.00186	CcSEcCtD
Quinidine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000208	0.00186	CcSEcCtD
Quinidine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000206	0.00184	CcSEcCtD
Quinidine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.00183	CcSEcCtD
Quinidine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000203	0.00181	CcSEcCtD
Quinidine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000203	0.00181	CcSEcCtD
Quinidine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000202	0.0018	CcSEcCtD
Quinidine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.0018	CcSEcCtD
Quinidine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.00179	CcSEcCtD
Quinidine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.00179	CcSEcCtD
Quinidine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00178	CcSEcCtD
Quinidine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000198	0.00177	CcSEcCtD
Quinidine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00177	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.00177	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000198	0.00177	CcSEcCtD
Quinidine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00174	CcSEcCtD
Quinidine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000195	0.00174	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000194	0.00173	CcSEcCtD
Quinidine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000193	0.00173	CcSEcCtD
Quinidine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000193	0.00173	CcSEcCtD
Quinidine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.00171	CcSEcCtD
Quinidine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00019	0.0017	CcSEcCtD
Quinidine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000188	0.00168	CcSEcCtD
Quinidine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000187	0.00167	CcSEcCtD
Quinidine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.00167	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00167	CcSEcCtD
Quinidine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000183	0.00164	CcSEcCtD
Quinidine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.00163	CcSEcCtD
Quinidine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000181	0.00162	CcSEcCtD
Quinidine—Purpura—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00161	CcSEcCtD
Quinidine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00018	0.00161	CcSEcCtD
Quinidine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000179	0.0016	CcSEcCtD
Quinidine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000179	0.0016	CcSEcCtD
Quinidine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.0016	CcSEcCtD
Quinidine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000178	0.0016	CcSEcCtD
Quinidine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000178	0.00159	CcSEcCtD
Quinidine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000178	0.00159	CcSEcCtD
Quinidine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000177	0.00158	CcSEcCtD
Quinidine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000177	0.00158	CcSEcCtD
Quinidine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00158	CcSEcCtD
Quinidine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000174	0.00155	CcSEcCtD
Quinidine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000172	0.00154	CcSEcCtD
Quinidine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000172	0.00154	CcSEcCtD
Quinidine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00153	CcSEcCtD
Quinidine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.00153	CcSEcCtD
Quinidine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.00153	CcSEcCtD
Quinidine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00153	CcSEcCtD
Quinidine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000171	0.00153	CcSEcCtD
Quinidine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000169	0.00151	CcSEcCtD
Quinidine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000169	0.00151	CcSEcCtD
Quinidine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000169	0.00151	CcSEcCtD
Quinidine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000169	0.00151	CcSEcCtD
Quinidine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00151	CcSEcCtD
Quinidine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000168	0.0015	CcSEcCtD
Quinidine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.0015	CcSEcCtD
Quinidine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000168	0.0015	CcSEcCtD
Quinidine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000168	0.0015	CcSEcCtD
Quinidine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.0015	CcSEcCtD
Quinidine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.00148	CcSEcCtD
Quinidine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.00148	CcSEcCtD
Quinidine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00148	CcSEcCtD
Quinidine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.00145	CcSEcCtD
Quinidine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00145	CcSEcCtD
Quinidine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00145	CcSEcCtD
Quinidine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.00143	CcSEcCtD
Quinidine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00016	0.00143	CcSEcCtD
Quinidine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00016	0.00143	CcSEcCtD
Quinidine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.00142	CcSEcCtD
Quinidine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000156	0.0014	CcSEcCtD
Quinidine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.00139	CcSEcCtD
Quinidine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000156	0.00139	CcSEcCtD
Quinidine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.00137	CcSEcCtD
Quinidine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000153	0.00137	CcSEcCtD
Quinidine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000153	0.00137	CcSEcCtD
Quinidine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000152	0.00136	CcSEcCtD
Quinidine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00135	CcSEcCtD
Quinidine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00015	0.00134	CcSEcCtD
Quinidine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000148	0.00133	CcSEcCtD
Quinidine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.00133	CcSEcCtD
Quinidine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00131	CcSEcCtD
Quinidine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000145	0.0013	CcSEcCtD
Quinidine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00129	CcSEcCtD
Quinidine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.00129	CcSEcCtD
Quinidine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00128	CcSEcCtD
Quinidine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00128	CcSEcCtD
Quinidine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00014	0.00126	CcSEcCtD
Quinidine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00014	0.00125	CcSEcCtD
Quinidine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00125	CcSEcCtD
Quinidine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000138	0.00123	CcSEcCtD
Quinidine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000138	0.00123	CcSEcCtD
Quinidine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.00122	CcSEcCtD
Quinidine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000137	0.00122	CcSEcCtD
Quinidine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000137	0.00122	CcSEcCtD
Quinidine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.00122	CcSEcCtD
Quinidine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000136	0.00121	CcSEcCtD
Quinidine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.00121	CcSEcCtD
Quinidine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.00121	CcSEcCtD
Quinidine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.00121	CcSEcCtD
Quinidine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000135	0.00121	CcSEcCtD
Quinidine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000134	0.0012	CcSEcCtD
Quinidine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000134	0.0012	CcSEcCtD
Quinidine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000133	0.00119	CcSEcCtD
Quinidine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.00117	CcSEcCtD
Quinidine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.00116	CcSEcCtD
Quinidine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.00116	CcSEcCtD
Quinidine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.00115	CcSEcCtD
Quinidine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.00115	CcSEcCtD
Quinidine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.00115	CcSEcCtD
Quinidine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000129	0.00115	CcSEcCtD
Quinidine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.00115	CcSEcCtD
Quinidine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00115	CcSEcCtD
Quinidine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.00113	CcSEcCtD
Quinidine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00113	CcSEcCtD
Quinidine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.00111	CcSEcCtD
Quinidine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00109	CcSEcCtD
Quinidine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.00109	CcSEcCtD
Quinidine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000121	0.00108	CcSEcCtD
Quinidine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00012	0.00107	CcSEcCtD
Quinidine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.00105	CcSEcCtD
Quinidine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.00103	CcSEcCtD
Quinidine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.00102	CcSEcCtD
Quinidine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.00101	CcSEcCtD
Quinidine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000112	0.001	CcSEcCtD
Quinidine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000996	CcSEcCtD
Quinidine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00097	CcSEcCtD
Quinidine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000105	0.00094	CcSEcCtD
Quinidine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000934	CcSEcCtD
Quinidine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000934	CcSEcCtD
Quinidine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	9.85e-05	0.000881	CcSEcCtD
Quinidine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	9.68e-05	0.000865	CcSEcCtD
Quinidine—Agitation—Prednisone—chronic obstructive pulmonary disease	9.61e-05	0.000859	CcSEcCtD
Quinidine—Angioedema—Prednisone—chronic obstructive pulmonary disease	9.55e-05	0.000854	CcSEcCtD
Quinidine—Vertigo—Prednisone—chronic obstructive pulmonary disease	9.39e-05	0.00084	CcSEcCtD
Quinidine—Syncope—Prednisone—chronic obstructive pulmonary disease	9.38e-05	0.000838	CcSEcCtD
Quinidine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	9.33e-05	0.000834	CcSEcCtD
Quinidine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	9.19e-05	0.000821	CcSEcCtD
Quinidine—Convulsion—Prednisone—chronic obstructive pulmonary disease	9.06e-05	0.00081	CcSEcCtD
Quinidine—Myalgia—Prednisone—chronic obstructive pulmonary disease	8.9e-05	0.000796	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	8.84e-05	0.00079	CcSEcCtD
Quinidine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	8.65e-05	0.000773	CcSEcCtD
Quinidine—Oedema—Prednisone—chronic obstructive pulmonary disease	8.53e-05	0.000763	CcSEcCtD
Quinidine—Shock—Prednisone—chronic obstructive pulmonary disease	8.4e-05	0.00075	CcSEcCtD
Quinidine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	8.37e-05	0.000748	CcSEcCtD
Quinidine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	8.33e-05	0.000744	CcSEcCtD
Quinidine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	8.29e-05	0.000741	CcSEcCtD
Quinidine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	8.25e-05	0.000737	CcSEcCtD
Quinidine—Anorexia—Prednisone—chronic obstructive pulmonary disease	8.13e-05	0.000727	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	7.77e-05	0.000695	CcSEcCtD
Quinidine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	7.77e-05	0.000694	CcSEcCtD
Quinidine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	7.42e-05	0.000663	CcSEcCtD
Quinidine—Rash—Prednisolone—chronic obstructive pulmonary disease	7.4e-05	0.000662	CcSEcCtD
Quinidine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	7.4e-05	0.000661	CcSEcCtD
Quinidine—Headache—Prednisolone—chronic obstructive pulmonary disease	7.36e-05	0.000657	CcSEcCtD
Quinidine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	7.03e-05	0.000628	CcSEcCtD
Quinidine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	6.98e-05	0.000624	CcSEcCtD
Quinidine—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.98e-05	0.000623	CcSEcCtD
Quinidine—Urticaria—Prednisone—chronic obstructive pulmonary disease	6.78e-05	0.000606	CcSEcCtD
Quinidine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	6.75e-05	0.000603	CcSEcCtD
Quinidine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	6.75e-05	0.000603	CcSEcCtD
Quinidine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	6.29e-05	0.000562	CcSEcCtD
Quinidine—Asthenia—Prednisone—chronic obstructive pulmonary disease	6.12e-05	0.000547	CcSEcCtD
Quinidine—Pruritus—Prednisone—chronic obstructive pulmonary disease	6.04e-05	0.00054	CcSEcCtD
Quinidine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.84e-05	0.000522	CcSEcCtD
Quinidine—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.64e-05	0.000504	CcSEcCtD
Quinidine—Vomiting—Prednisone—chronic obstructive pulmonary disease	5.43e-05	0.000485	CcSEcCtD
Quinidine—Rash—Prednisone—chronic obstructive pulmonary disease	5.38e-05	0.000481	CcSEcCtD
Quinidine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	5.38e-05	0.00048	CcSEcCtD
Quinidine—Headache—Prednisone—chronic obstructive pulmonary disease	5.35e-05	0.000478	CcSEcCtD
Quinidine—Nausea—Prednisone—chronic obstructive pulmonary disease	5.07e-05	0.000453	CcSEcCtD
Quinidine—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	1.76e-05	0.000365	CbGpPWpGaD
Quinidine—CHRM2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	1.76e-05	0.000364	CbGpPWpGaD
Quinidine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.75e-05	0.000362	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.74e-05	0.000361	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	1.72e-05	0.000358	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.72e-05	0.000357	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	1.7e-05	0.000352	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	1.7e-05	0.000352	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.67e-05	0.000346	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.66e-05	0.000344	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.66e-05	0.000344	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.65e-05	0.000342	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.65e-05	0.000342	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.64e-05	0.00034	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.64e-05	0.000339	CbGpPWpGaD
Quinidine—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.64e-05	0.000339	CbGpPWpGaD
Quinidine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.63e-05	0.000337	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	1.63e-05	0.000337	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.62e-05	0.000336	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.61e-05	0.000334	CbGpPWpGaD
Quinidine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.61e-05	0.000333	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.6e-05	0.000332	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.56e-05	0.000323	CbGpPWpGaD
Quinidine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.54e-05	0.00032	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.53e-05	0.000318	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.53e-05	0.000317	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.53e-05	0.000317	CbGpPWpGaD
Quinidine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.52e-05	0.000316	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.52e-05	0.000315	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.51e-05	0.000313	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.5e-05	0.000311	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.5e-05	0.00031	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	1.49e-05	0.000309	CbGpPWpGaD
Quinidine—SCN5A—Axon guidance—IL6—chronic obstructive pulmonary disease	1.48e-05	0.000307	CbGpPWpGaD
Quinidine—SLCO1A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.45e-05	0.000301	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.42e-05	0.000294	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.4e-05	0.00029	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.4e-05	0.00029	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.4e-05	0.00029	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.39e-05	0.000287	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.38e-05	0.000286	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.38e-05	0.000285	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.37e-05	0.000285	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.37e-05	0.000284	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.36e-05	0.000281	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.34e-05	0.000278	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.34e-05	0.000277	CbGpPWpGaD
Quinidine—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.32e-05	0.000274	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.32e-05	0.000274	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.31e-05	0.000271	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.31e-05	0.000271	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.3e-05	0.00027	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.3e-05	0.000269	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.3e-05	0.000269	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	1.29e-05	0.000267	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.28e-05	0.000266	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.28e-05	0.000265	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.26e-05	0.000262	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.26e-05	0.000261	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.25e-05	0.000259	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.24e-05	0.000258	CbGpPWpGaD
Quinidine—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.24e-05	0.000257	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.24e-05	0.000257	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.24e-05	0.000256	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.22e-05	0.000254	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.21e-05	0.000251	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.21e-05	0.000251	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.21e-05	0.00025	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.2e-05	0.000248	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.2e-05	0.000248	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.18e-05	0.000244	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.17e-05	0.000243	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.17e-05	0.000243	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.15e-05	0.000238	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.15e-05	0.000238	CbGpPWpGaD
Quinidine—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.14e-05	0.000236	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.14e-05	0.000236	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.13e-05	0.000235	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.13e-05	0.000234	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.13e-05	0.000234	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.11e-05	0.000231	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.1e-05	0.000229	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.09e-05	0.000226	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.08e-05	0.000224	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.08e-05	0.000224	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.08e-05	0.000224	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.07e-05	0.000221	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.06e-05	0.000221	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.06e-05	0.00022	CbGpPWpGaD
Quinidine—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.06e-05	0.00022	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.06e-05	0.000219	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.06e-05	0.000219	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.04e-05	0.000215	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.04e-05	0.000215	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.01e-05	0.000209	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.01e-05	0.000209	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1e-05	0.000207	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	9.91e-06	0.000205	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.83e-06	0.000204	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	9.73e-06	0.000202	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	9.71e-06	0.000201	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.69e-06	0.000201	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.64e-06	0.0002	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.62e-06	0.000199	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	9.51e-06	0.000197	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.42e-06	0.000195	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	9.31e-06	0.000193	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	9.25e-06	0.000192	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.03e-06	0.000187	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.02e-06	0.000187	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	9e-06	0.000187	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.99e-06	0.000186	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.89e-06	0.000184	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.88e-06	0.000184	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.88e-06	0.000184	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.84e-06	0.000183	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	8.78e-06	0.000182	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	8.68e-06	0.00018	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.56e-06	0.000177	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	8.5e-06	0.000176	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.39e-06	0.000174	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.29e-06	0.000172	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.28e-06	0.000172	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.27e-06	0.000171	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.23e-06	0.000171	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.19e-06	0.00017	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	8.16e-06	0.000169	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—ALB—chronic obstructive pulmonary disease	8.15e-06	0.000169	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.15e-06	0.000169	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	8.05e-06	0.000167	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	8.01e-06	0.000166	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	8e-06	0.000166	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8e-06	0.000166	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.86e-06	0.000163	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.84e-06	0.000163	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.83e-06	0.000162	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—NOS3—chronic obstructive pulmonary disease	7.8e-06	0.000162	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.78e-06	0.000161	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.71e-06	0.00016	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.68e-06	0.000159	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.51e-06	0.000156	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.44e-06	0.000154	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.38e-06	0.000153	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	7.35e-06	0.000152	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.31e-06	0.000152	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.24e-06	0.00015	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.1e-06	0.000147	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.01e-06	0.000145	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—ALB—chronic obstructive pulmonary disease	6.8e-06	0.000141	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.77e-06	0.00014	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.69e-06	0.000139	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.68e-06	0.000138	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.67e-06	0.000138	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.63e-06	0.000137	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	6.61e-06	0.000137	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.58e-06	0.000136	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	6.55e-06	0.000136	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.53e-06	0.000135	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	6.51e-06	0.000135	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.44e-06	0.000134	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.4e-06	0.000133	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.22e-06	0.000129	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.16e-06	0.000128	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.13e-06	0.000127	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.11e-06	0.000127	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.07e-06	0.000126	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	6.03e-06	0.000125	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.01e-06	0.000125	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6e-06	0.000124	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	5.98e-06	0.000124	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.97e-06	0.000124	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.9e-06	0.000122	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	5.82e-06	0.000121	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.81e-06	0.00012	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.69e-06	0.000118	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.66e-06	0.000117	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.66e-06	0.000117	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.65e-06	0.000117	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	5.6e-06	0.000116	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.57e-06	0.000115	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.57e-06	0.000115	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.56e-06	0.000115	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.51e-06	0.000114	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.46e-06	0.000113	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.42e-06	0.000112	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	5.34e-06	0.000111	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	5.33e-06	0.000111	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.22e-06	0.000108	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.22e-06	0.000108	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.19e-06	0.000108	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.11e-06	0.000106	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	5.11e-06	0.000106	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.1e-06	0.000106	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	4.97e-06	0.000103	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.92e-06	0.000102	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.92e-06	0.000102	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.85e-06	0.000101	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.85e-06	0.000101	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.75e-06	9.85e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.64e-06	9.61e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.59e-06	9.52e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.57e-06	9.47e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.53e-06	9.39e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.52e-06	9.37e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.37e-06	9.06e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	4.32e-06	8.96e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.28e-06	8.88e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.26e-06	8.83e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.22e-06	8.75e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.04e-06	8.37e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4e-06	8.3e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.99e-06	8.27e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	3.95e-06	8.18e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	3.94e-06	8.17e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.93e-06	8.14e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.87e-06	8.03e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	3.87e-06	8.02e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.81e-06	7.89e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.78e-06	7.83e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.7e-06	7.67e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	3.65e-06	7.56e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.64e-06	7.54e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.63e-06	7.53e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.61e-06	7.48e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.49e-06	7.23e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.42e-06	7.09e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	3.34e-06	6.93e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.23e-06	6.68e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	3.2e-06	6.63e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.07e-06	6.36e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.03e-06	6.28e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.99e-06	6.19e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.92e-06	6.05e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	2.91e-06	6.04e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.79e-06	5.77e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.78e-06	5.77e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2.74e-06	5.69e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	2.72e-06	5.64e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.64e-06	5.47e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.63e-06	5.44e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.62e-06	5.43e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.6e-06	5.39e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.4e-06	4.98e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.36e-06	4.89e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.33e-06	4.82e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.22e-06	4.61e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.98e-06	4.1e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.81e-06	3.75e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.79e-06	3.72e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.72e-06	3.56e-05	CbGpPWpGaD
